U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07175766) titled 'Dachundou No Sugar Added Soymilk for Lipid Modulation' on Sept. 02.
Brief Summary: Cardiovascular disease is one of the leading causes of death worldwide, and high cholesterol is a major risk factor. Diet is known to play an important role in managing blood lipids. Soy milk is a common plant-based drink rich in protein and isoflavones, which may help lower cholesterol and improve heart health.
This clinical trial will evaluate whether daily consumption of Dachundou No Sugar Added Soymilk can help reduce cholesterol levels in adults with elevated total cholesterol (>=200 mg/dL). A total of 50 participants aged 18-65 will be recruit...